Why is CLYM Down Today?
About Climb Bio, Inc. Common Stock
Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. its product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has the potential to treat a broad range of B-cell-mediated di...
Overall Confidence: 65%
Based on news, social sentiment, options activity, and sector analysis
✅ Move Confirmation
UNCONFIRMED - Low volume suggests this move may not be sustainable.
📍 Sector Context
PHARMACEUTICAL PREPARATIONS sector: -1.8%
Market Comparison
Quick Trade Ideas
Options strategies to consider for CLYM's -10% move
No Options Available
CLYM doesn't have listed options or options data is currently unavailable.
Try another stock in our Options Calculator →🔔 Get CLYM Alerts
We'll notify you when CLYM's trend changes or a new signal fires.
Data refreshes every 30 minutes during market hours
Historical Context
CLYM has moved more than 3.0% down on 62 occasions in the past year.
Frequently Asked Questions
Why is CLYM stock down today?
This appears to be a sector-wide move. The PHARMACEUTICAL PREPARATIONS sector is down 1.8% on average.
Is CLYM stock a buy or sell right now?
Based on current analysis, CLYM shows 65% confidence in today's move. Volume is low which does not confirm the trend. View full buy/sell analysis →
What is the CLYM stock price target?
CLYM is currently trading at $9.82. Based on today's momentum, the expected short-term range is $9.53 - $10.02. See long-term price prediction →
Will CLYM stock continue falling?
Our analysis shows a 45% probability that CLYM's move continues in the next 1-3 days. Key level to watch: $9.33 (support).
Is CLYM stock oversold or overbought?
CLYM's RSI (Relative Strength Index) is currently at 30.6. This shows bearish momentum - the stock has negative momentum but isn't oversold yet.
What is the momentum for CLYM stock?
CLYM's 10-day momentum indicator is at -1.12. Negative momentum - the stock has mild downward pressure which may continue short-term.
Is CLYM outperforming or underperforming the market?
CLYM (-9.99%) is currently significantly underperforming the market (-8.9% vs SPY). Today, the S&P 500 (SPY) is down -1.11%, and Nasdaq (QQQ) is down -2.50%.
What does MACD indicate for CLYM?
CLYM's MACD (-0.94) is currently below the signal line (-0.93), indicating a bearish trend. This technical signal suggests selling pressure is dominant. The trend strength (ADX: 42.6) is strong.
Is CLYM in an uptrend or downtrend?
Based on moving average analysis, CLYM is in a bearish trend. The price ($9.82) is trading below both the 20-day SMA ($11.36) and 50-day SMA ($13.7). This alignment typically indicates sustained downward pressure.
Check Why Another Stock is Moving
Enter any ticker symbol to see real-time analysis